FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
For Immediate Release: December 08, 2025 The U.S. Food and Drug Administration today announced it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplant (HSCT) therapy to treat patients with severe aplastic anemia (SAA). …